Suppr超能文献

核基质蛋白NRP/B作为E2F介导的转录活性的转录抑制因子。

The Nuclear Matrix Protein, NRP/B, Acts as a Transcriptional Repressor of E2F-mediated Transcriptional Activity.

作者信息

Choi Jina, Yang Eun Sung, Cha Kiweon, Whang John, Choi Woo-Jung, Avraham Shalom, Kim Tae-Aug

机构信息

CHA Cancer Institute, CHA University, Seoul, Korea.

Cancer Cell Biology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

出版信息

J Cancer Prev. 2014 Sep;19(3):187-98. doi: 10.15430/JCP.2014.19.3.187.

Abstract

BACKGROUND

NRP/B, a family member of the BTB/Kelch repeat proteins, is implicated in neuronal and cancer development, as well as the regulation of oxidative stress responses in breast and brain cancer. Our previous studies indicate that the NRP/B-BTB/POZ domain is involved in the dimerization of NRP/B and in a complex formation with the tumor suppressor, retinoblastoma protein. Although much evidence supports the potential role of NRP/B as a tumor suppressor, the molecular mechanisms of NRP/B action on E2F transcription factors have not been elucidated.

METHODS

Three-dimensional modeling of NRP/B was used to generate point mutations in the BTB/Kelch domains. Tet-on inducible NRP/B expression was established. The NRP/B deficient breast cancer cell line, MDA-MB-231, was generated using lentiviral shNRP/B to evaluate the effect of NRP/B on cell proliferation, invasion and migration. Immunoprecipitation was performed to verify the interaction of NRP/B with E2F and histone deacetylase (HDAC-1), and the expression level of NRP/B protein was analyzed by Western blot analysis. Changes in cell cycle were determined by flow cytometry. Transcriptional activities of E2F transcription factors were measured by chloramphenicol acetyltransferase (CAT) activity.

RESULTS

Ectopic overexpression of NRP/B demonstrated that the NRP/B-BTB/POZ domain plays a critical role in E2F-mediated transcriptional activity. Point mutations within the BTB/POZ domain restored E2-promoter activity inhibited by NRP/B. Loss of NRP/B enhanced the proliferation and migration of breast cancer cells. Endogenous NRP/B interacted with E2F and HDAC1. Treatement with an HDAC inhibitor, trichostatin A (TSA), abolished the NRP/B-mediated suppression of E2-promoter activity. Gain or loss of NRP/B in HeLa cells confirmed the transcriptional repressive capability of NRP/B on the E2F target genes, Cyclin E and HsORC (Homo sapiens Origin Recognition Complex).

CONCLUSIONS

The present study shows that NRP/B acts as a transcriptional repressor by interacting with the co-repressors, HDAC1, providing new insight into the molecular mechanisms of NRP/B on tumor suppression.

摘要

背景

NRP/B是BTB/Kelch重复蛋白家族成员,与神经元和癌症发展以及乳腺癌和脑癌中氧化应激反应的调节有关。我们之前的研究表明,NRP/B的BTB/POZ结构域参与NRP/B的二聚化以及与肿瘤抑制蛋白视网膜母细胞瘤蛋白形成复合物。尽管有很多证据支持NRP/B作为肿瘤抑制因子的潜在作用,但NRP/B对E2F转录因子作用的分子机制尚未阐明。

方法

利用NRP/B的三维建模在BTB/Kelch结构域产生点突变。建立四环素诱导的NRP/B表达体系。使用慢病毒shNRP/B构建NRP/B缺陷的乳腺癌细胞系MDA-MB-231,以评估NRP/B对细胞增殖、侵袭和迁移的影响。进行免疫沉淀以验证NRP/B与E2F和组蛋白去乙酰化酶(HDAC-)的相互作用,并通过蛋白质免疫印迹分析来分析NRP/B蛋白的表达水平。通过流式细胞术确定细胞周期的变化。通过氯霉素乙酰转移酶(CAT)活性测量E2F转录因子的转录活性。

结果

NRP/B的异位过表达表明NRP/B的BTB/POZ结构域在E2F介导的转录活性中起关键作用。BTB/POZ结构域内的点突变恢复了被NRP/B抑制的E2启动子活性。NRP/B的缺失增强了乳腺癌细胞增殖和迁移。内源性NRP/B与E2F和HDAC1相互作用。用组蛋白去乙酰化酶抑制剂曲古抑菌素A(TSA)处理消除了NRP/B介导的对E2启动子活性的抑制。HeLa细胞中NRP/B的增减证实了NRP/B对E2F靶基因细胞周期蛋白E和HsORC(人类起源识别复合物)的转录抑制能力。

结论

本研究表明,NRP/B通过与共抑制因子HDAC1相互作用发挥转录抑制作用,为NRP/B的肿瘤抑制分子机制提供了新的见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd65/4189505/94528943251b/jcp-19-187f1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验